Surveillance of hepatocellular carcinoma by medical imaging
Effective treatments for early-stage hepatocellular carcinoma (HCC) have provided the rationale for HCC surveillance since detection of the disease at an early stage is associated with more favorable outcome. In a prospective multi-institutional diagnostic study, Park et al . (1) evaluated the adde...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2019
|
| In: |
Quantitative imaging in medicine and surgery
Year: 2019, Volume: 9, Issue: 11, Pages: 1904-1910 |
| ISSN: | 2223-4306 |
| DOI: | 10.21037/qims.2019.10.04 |
| Online Access: | Resolving-System, Volltext: http://dx.doi.org/10.21037/qims.2019.10.04 Verlag, Volltext: http://qims.amegroups.com/article/view/30807 
|
| Author Notes: | Christoph F. Dietrich, Andreas Teufel, Claude B. Sirlin, Yi Dong |
| Summary: | Effective treatments for early-stage hepatocellular carcinoma (HCC) have provided the rationale for HCC surveillance since detection of the disease at an early stage is associated with more favorable outcome. In a prospective multi-institutional diagnostic study, Park et al . (1) evaluated the added value of (perfluorobutane) contrast-enhanced ultrasound (CEUS) when combined with conventional B-mode ultrasound (US) as an HCC surveillance tool in participants with liver cirrhosis using a single arm, intraindividual comparison study design. |
|---|---|
| Item Description: | Accepted for publication Oct 05, 2019 Gesehen am 07.02.2020 |
| Physical Description: | Online Resource |
| ISSN: | 2223-4306 |
| DOI: | 10.21037/qims.2019.10.04 |